Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Metformin/Sodium-glucose-transporter-2-inhibitors

High anion-gap metabolic acidosis and non-anion-gap metabolic acidosis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Narang DK, et al. Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor. Journal of the Endocrine Society 4 (Suppl.): A983-A984 abstr. SUN-673, May 2020. Available from: URL: https://dx.doi.org/10.1210/jendso/bvaa046.1953 [abstract] Narang DK, et al. Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor. Journal of the Endocrine Society 4 (Suppl.): A983-A984 abstr. SUN-673, May 2020. Available from: URL: https://​dx.​doi.​org/​10.​1210/​jendso/​bvaa046.​1953 [abstract]
Metadaten
Titel
Metformin/Sodium-glucose-transporter-2-inhibitors
High anion-gap metabolic acidosis and non-anion-gap metabolic acidosis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57609-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Bevacizumab

Case report

Pembrolizumab

Case report

Prednisone

Case report

Ibrutinib

Case report

Multiple drugs